WEST PHARMACEUTICAL SERVICES

West Pharmaceutical Services (WST) rises modestly, driven by biotech growth and a robust innovation pipeline—an attractive long‑term investment in pharma packaging and delivery.

West Pharmaceutical Services (WST) stock rises 1.2% as it announces a small option issue to lift trading limits, not raise capital, while shares hit a 52‑week high.

West Pharmaceutical Services hikes dividend 18%—but is the growth real or just a yield strategy? Explore the risk and reward of WST’s 34th consecutive payout.

West Pharmaceutical Services (WST) stock: 24‑hour dip, 6% month‑rise, 52‑week peak $387.01. Insight into pharma packaging, market cap $27B, and peer comparison.